Positive antiphospholipid antibodies linked to increased cardiovascular risk...
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, describes a link between positive antiphospholipid antibodies and an increased risk of future...
View ArticleClotting risk from birth control normalizes within weeks of stopping hormonal...
Using birth control pills and other hormone-based contraceptives is known to elevate the risk of blood clots about three-fold, but a new study suggests that this risk largely goes away within two to...
View ArticleAbelacimab significantly reduces bleeding risk in atrial fibrillation...
An experimental anti-clotting medication, abelacimab, significantly reduced bleeding among people with atrial fibrillation (or AFib) who were at risk of stroke, according to results of the AZALEA-TIMI...
View ArticleInitial high-risk antibody profile for antiphospholipid syndrome tends to...
A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients.
View ArticleMajor trial finds apixaban reduces stroke risk in patients with...
The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable by a pacemaker or other implanted cardiac electronic...
View ArticleNew decision rule can reduce unnecessary head CT scans in older adults after...
How do emergency department staff determine whether older adults who have fallen need imaging? A new decision rule will help emergency department physicians determine which older adults need imaging...
View ArticleCommon oral anticoagulant rivaroxaban linked to highest risk of bleeding...
When diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a future clot.
View ArticleComprehensive insights on pathophysiology and clinical management of atrial...
Atrial fibrillation (AF) is a major global health concern impacting millions and causing symptoms like palpitations, dyspnea, fatigue, dizziness, and chest discomfort.
View ArticleRevolutionary bio-sponge halts bleeding instantly
More than 11 million people in the United States take anticoagulation or antiplatelet medications, such as heparin or aspirin, to treat serious conditions like heart attack and stroke.
View ArticleStudy: Most stroke survivors can safely take two types of common antidepressants
Most stroke survivors were able to safely take two types of common antidepressants, according to a preliminary study to be presented at the American Stroke Association's International Stroke Conference...
View ArticleUnderstanding long COVID: A call for better diagnosis and treatment
A recent review in Nature Reviews Microbiology summarizes the complex mechanisms, significant impacts, and the urgent need for enhanced diagnostics and treatments for long COVID, affecting over 65...
View ArticleHow do acetylsalicylic acid and warfarin interact with various nutrients?
45 drug-nutrient interactions (DNIs) that modify micro-nutritional status, particularly focusing on how acetylsalicylic acid (ASA) and warfarin may affect patients through various mechanisms.
View Article
